Halozyme Therapeutics | Eiendeler



Assets Endring Dato
Acadia Pharmaceuticals USD 1.19B 210.89M 2024-12
Agios Pharmaceuticals USD 1.66B 128.6M 2024-12
Alnylam Pharmaceuticals USD 4.24B 34.94M 2024-12
Amarin USD 750.62M 49.24M 2024-09
Amgen USD 91.84B 956M 2024-12
Baxter International USD 25.78B 894M 2024-12
Cytokinetics USD 1.4B 34.39M 2024-12
DBV Technologies USD 93.06M 21.14M 2024-09
Eli Lilly USD 78.71B 3.11B 2024-12
Halozyme Therapeutics USD 2.06B 54.55M 2024-12
Indivior 1.46B 71M 2024-09
Intra Cellular Therapies USD 1.37B 42.47M 2024-12
Ionis Pharmaceuticals USD 3B 77.42M 2024-12
MannKind USD 393.84M 70.36M 2024-12
Pfizer USD 213.4B 6.08B 2024-12
United Therapeutics USD 7.36B 240.9M 2024-12



Halozyme Therapeutics Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.